These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9883002

  • 21. Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study.
    Spira J, Plyushch O, Zozulya N, Yatuv R, Dayan I, Bleicher A, Robinson M, Baru M.
    Haemophilia; 2010 Nov; 16(6):910-8. PubMed ID: 20491957
    [Abstract] [Full Text] [Related]

  • 22. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
    Valentino LA, Cooper DL, Goldstein B.
    Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Recombinant factor VIIa does not induce hypercoagulability in vitro.
    Gallistl S, Cvirn G, Muntean W.
    Thromb Haemost; 1999 Feb; 81(2):245-9. PubMed ID: 10064000
    [Abstract] [Full Text] [Related]

  • 29. Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B.
    Hoots WK, Leissinger C, Stabler S, Schwartz BA, White G, Dasani H, Massion C, Negrier C, Schindel F, Schulman S.
    Haemophilia; 2003 Mar; 9(2):164-72. PubMed ID: 12614367
    [Abstract] [Full Text] [Related]

  • 30. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G, Savidge GF.
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs.
    Négrier C, Menart C, Attali O, Petit PY, Lienhart A, Dechavanne M, Ingerslev J.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S135-41. PubMed ID: 9819045
    [Abstract] [Full Text] [Related]

  • 36. Entering new areas in known fields: recombinant fusion protein linking recombinant factor VIIa with recombinant albumin (rVIIa-FP) - advancing the journey.
    Négrier C.
    Thromb Res; 2016 May; 141 Suppl 3():S9-S12. PubMed ID: 27288065
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
    Kawasaki Y, Saeki N, Kawamoto M, Yuge O, Fujii T.
    Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
    [Abstract] [Full Text] [Related]

  • 39. Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.
    Astermark J, Rocino A, Von Depka M, Van Den Berg HM, Gringeri A, Mantovani LG, Morado M, Garrido RP, Schiavoni M, Villar A, Windyga J, EHTSB.
    Haemophilia; 2007 Jan; 13(1):38-45. PubMed ID: 17212723
    [Abstract] [Full Text] [Related]

  • 40. Continuous infusion of coagulation factors.
    Batorova A, Martinowitz U.
    Haemophilia; 2002 May; 8(3):170-7. PubMed ID: 12010406
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.